[HTML][HTML] The PARP way to epigenetic changes

S Ummarino, C Hausman, A Di Ruscio - Genes, 2021 - mdpi.com
ADP-ribosylation, is a reversible post-translational modification implicated in major
biological functions. Poly ADP-ribose polymerases (PARP) are specialized enzymes that …

Induced pluripotent stem cell‐derived extracellular vesicles: A novel approach for cell‐free regenerative medicine

B Taheri, M Soleimani, S Fekri Aval… - Journal of Cellular …, 2019 - Wiley Online Library
In recent years, induced pluripotent stem cells (iPSCs) have been considered as a
promising approach in the field of regenerative medicine. iPSCs can be generated from …

[HTML][HTML] Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features

A Guadall, E Lesteven, G Letort, SA Toor… - Thrombosis and …, 2018 - thieme-connect.com
Thromboembolic events are the main cause of mortality in BCR-ABL1-negative
myeloproliferative neoplasms (MPNs) but their underlying mechanisms are largely …

Heterogeneity of tumors in breast cancer: implications and prospects for prognosis and therapeutics

N Tuasha, B Petros - Scientifica, 2020 - Wiley Online Library
Breast cancer is the most commonly diagnosed form of cancer in women comprising 16% of
all female cancers. The disease shows high intertumoral and intratumoral heterogeneity …

[HTML][HTML] Induced pluripotent stem cell-derived red blood cells and platelet concentrates: from bench to bedside

D Focosi, G Amabile - Cells, 2017 - mdpi.com
Red blood cells and platelets are anucleate blood components indispensable for oxygen
delivery and hemostasis, respectively. Derivation of these blood elements from induced …

Conditional reprogramming: Modeling urological cancer and translation to clinics

W Liu, L Ju, S Cheng, G Wang, K Qian… - Clinical and …, 2020 - Wiley Online Library
Patient‐derived models, including cell models (organoids and conditionally reprogrammed
cells [CRCs]) and patient‐derived xenografts, are urgently needed for both basic and …

[HTML][HTML] Management of ß-thalassemia–consensus and controversies!

MV Manglani, PS Kini - Pediatric Hematology Oncology Journal, 2017 - Elsevier
The mainstay of treatment of ß-Thalassemia major includes life-long regular packed red cell
transfusions and iron chelation. With advances in understanding the molecular biology and …

Application of induced pluripotent stem cell technology for the investigation of hematological disorders

H Dolatshad, D Tatwavedi, D Ahmed… - Advances in biological …, 2019 - Elsevier
Induced pluripotent stem cells (iPSCs) were first described over a decade ago and are
currently used in various basic biology and clinical research fields. Recent advances in the …

Therapeutic approaches in patients with β-thalassemia

M Eini, M Shoae, E Miri-moghaddam - Iranian Journal of Pediatric …, 2022 - ijpho.ssu.ac.ir
Abstract Beta-thalassemia (β-thal) is a congenital hemoglobinopathy explained by a
decreased level (β+) or absence (βο) of β-globin gene expression. Microcytic hypochromic …

Induced pluripotent stem cells from ovarian tissue

S Salas, N Ng, B Gerami‐Naini… - Current Protocols in …, 2017 - Wiley Online Library
Yamanaka and colleagues revolutionized stem cell biology and regenerative medicine by
observing that somatic cells can be reprogrammed into pluripotent stem cells. Evidence …